Advanced search
Publication Cover
Emerging Microbes & Infections Volume 11, 2022 - Issue 1
Submit an article Journal homepage
3,903
Views
33
CrossRef citations to date
0
Altmetric
Coronaviruses

The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants

Yuxin Chena Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, People’s Republic of China;b Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, People’s Republic of ChinaView further author information
,
Lin Chenc Department of Laboratory Medicine, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, People’s Republic of ChinaView further author information
,
Shengxia Yinb Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, People’s Republic of China;d Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, People’s Republic of ChinaView further author information
,
Yue Taoc Department of Laboratory Medicine, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, People’s Republic of ChinaView further author information
,
Liguo Zhue Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, People’s Republic of ChinaView further author information
,
Xin Tongb Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, People’s Republic of China;d Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, People’s Republic of ChinaView further author information
,
Minxin Maod Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, People’s Republic of ChinaView further author information
,
Ming Lid Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, People’s Republic of ChinaView further author information
,
Yawen Wand Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, People’s Republic of ChinaView further author information
,
Jun Nia Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, People’s Republic of ChinaView further author information
,
Xiaoyun Jib Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, People’s Republic of China;f State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, People’s Republic of ChinaView further author information
,
Xianchi Dongb Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, People’s Republic of China;g Engineering Research Center of Protein and Peptide Medicine, Ministry of Education, Nanjing, People’s Republic of ChinaView further author information
,
Jie Lib Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, People’s Republic of China;d Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, People’s Republic of ChinaView further author information
,
Rui Huangb Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, People’s Republic of China;d Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, People’s Republic of ChinaView further author information
,
Ya Shene Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, People’s Republic of ChinaView further author information
,
Han Shena Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Changjun Baoe Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Chao Wub Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, People’s Republic of China;d Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 1524-1536 | Received 15 Feb 2022, Accepted 19 May 2022, Published online: 02 Jun 2022

Citations (33)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Lili Wang, Chuang Li, Wanting Li, Liwei Zhao, Tiantian Zhao, Lin Chen, Ming Li, Jing Fan, Jiayan Li, Chao Wu & Yuxin Chen. (2023) Coronavac inactivated vaccine triggers durable, cross-reactive Fc-mediated phagocytosis activities. Emerging Microbes & Infections 12:2.
Read now
Xiaoxu Zhang, Bixia Hong, Peng Wei, Pengfei Pei, Haifeng Xu, Long Chen, Yigang Tong, Jialin Chen, Shi-Zhong Luo, Huahao Fan & Chengzhi He. (2022) Pathogen-host adhesion between SARS-CoV-2 spike proteins from different variants and human ACE2 studied at single-molecule and single-cell levels. Emerging Microbes & Infections 11:1, pages 2658-2669.
Read now
Weihao Shao, Xiaorui Chen, Caifang Zheng, Haoshuang Liu, Gaili Wang, Bowen Zhang, Zhiyuan Li & Weidong Zhang. (2022) Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern in real-world: a literature review and meta-analysis. Emerging Microbes & Infections 11:1, pages 2383-2392.
Read now

Articles from other publishers (30)

Yuxin Chen, Tiantian Zhao, Lin Chen, Guozhi Jiang, Yu Geng, Wanting Li, Shengxia Yin, Xin Tong, Yue Tao, Jun Ni, Qiuhan Lu, Mingzhe Ning & Chao Wu. (2024) SARS-CoV-2 Omicron infection augments the magnitude and durability of systemic and mucosal immunity in triple-dose CoronaVac recipients. mBio 15:4.
Crossref
Tiandan Xiang, Xufeng Quan, Hang Jia, Hua Wang, Boyun Liang, Sumeng Li, Xiaoyan Wang, Huadong Li, Xuemei Feng, Lei Fan, Ling Xu, Tong Wang, Shue Xiong, Dongliang Yang, Jia Liu & Xin Zheng. (2024) Omicron breakthrough infections after triple‐dose inactivated COVID ‐19 vaccination: A comprehensive analysis of antibody and T‐cell responses . Immunology.
Crossref
Xun Wang, Shujun Jiang, Wentai Ma, Xiangnan Li, Kaifeng Wei, Faren Xie, Chaoyue Zhao, Xiaoyu Zhao, Shidi Wang, Chen Li, Rui Qiao, Yuchen Cui, Yanjia Chen, Jiayan Li, Guonan Cai, Changyi Liu, Jizhen Yu, Jixi Li, Zixin Hu, Wenhong Zhang, Shibo Jiang, Mingkun Li, Yanliang Zhang & Pengfei Wang. (2024) Enhanced neutralization of SARS-CoV-2 variant BA.2.86 and XBB sub-lineages by a tetravalent COVID-19 vaccine booster. Cell Host & Microbe 32:1, pages 25-34.e5.
Crossref
Geon Young Ko, Jihyun Lee, Hyunjoo Bae, Ji Hyeong Ryu, Hye-Sun Park, Hyunhye Kang, Jin Jung, Ae-Ran Choi, Raeseok Lee, Dong-Gun Lee & Eun-Jee Oh. (2023) Longitudinal Analysis of SARS-CoV-2-Specific Cellular and Humoral Immune Responses and Breakthrough Infection following BNT162b2/BNT162b2/BNT162b2 and ChAdOx1/ChAdOx1/BNT162b2 Vaccination: A Prospective Cohort in Naive Healthcare Workers. Vaccines 11:10, pages 1613.
Crossref
Ying Chen, Caiqin Hu, Zheng Wang, Junwei Su, Shuo Wang, Bin Li, Xiang Liu, Zhenzhen Yuan, Dan Li, Hong Wang, Biao Zhu & Yiming Shao. (2023) Immunity Induced by Inactivated SARS-CoV-2 Vaccine: Breadth, Durability, Potency, and Specificity in a Healthcare Worker Cohort. Pathogens 12:10, pages 1254.
Crossref
Cheng Cao, Junfeng Jiang, Min Liu, Yaping Dai, Tianzhi Chang, Tuo Ji & Fang Gong. (2023) Longitudinal evaluation of innate immune responses to three doses of CoronaVac vaccine. Frontiers in Immunology 14.
Crossref
Xiuli Shen, Yanling Hao, Shuhui Wang, Dan Li, Li Ren, Meiling Zhu, Shuo Wang, Jing Li, Wenqi Tang, Yuyu Fu, Ran Chen, Ying Liu & Yiming Shao. (2023) Sequential heterologous immunization with COVID-19 vaccines induces broader neutralizing responses against SARS-CoV-2 variants in comparison with homologous boosters. Vaccine 41:45, pages 6645-6653.
Crossref
Zhanwei Hu, Zhou Jin, Mengyun Zhou, Chunbo Zhang, Yingcong Bao, Xinran Gao & Guangfa Wang. (2023) CoronaVac and BBIBP‐CorV vaccines against SARS‐CoV‐2 during predominant circulation of Omicron BA.5.2 and BF.7 in China, a retrospective cohort study. Journal of Medical Virology 95:10.
Crossref
Soumya Sengupta, Shubham K. Shaw, Sanchari Chatterjee, Gargee Bhattacharya, Prakash K. Barik, Soma Chattopadhyay & Satish Devadas. (2023) Perturbations in spike‐specific peripheral T follicular helper cells in SARS‐CoV2 breakthrough convalescent individuals immunized by BBV152 vaccine. Journal of Medical Virology 95:9.
Crossref
Zhaomu Zeng, Xiuchao Geng, Xichao Wen, Yueyue Chen, Yixi Zhu, Zishu Dong, Liangchao Hao, Tingting Wang, Jifeng Yang, Ruobing Zhang, Kebin Zheng, Zhiwei Sun & Yuhao Zhang. (2023) Novel receptor, mutation, vaccine, and establishment of coping mode for SARS-CoV-2: current status and future. Frontiers in Microbiology 14.
Crossref
Pengcheng Zhou, Cheng Cao, Tuo Ji, Ting Zheng, Yaping Dai, Min Liu, Junfeng Jiang, Daoqi Sun, Zhonghu Bai, Xiaojie Lu & Fang Gong. (2023) Longitudinal analysis of memory Tfh cells and antibody response following CoronaVac vaccination. JCI Insight 8:15.
Crossref
Mollie Ailie Acheson Boyd, Alexandra Carey Hoppe, Anthony D Kelleher & C Mee Ling Munier. (2023) T follicular helper cell responses to SARS‐CoV ‐2 vaccination among healthy and immunocompromised adults . Immunology & Cell Biology 101:6, pages 504-513.
Crossref
Yifeng Luo, Qian Zhou, Xinyan Huang, Yuqi Ding, Xiangrong Ye, Jie Ding, Yukun Kuang, Yihao Liu, Sui Peng, Qingtang Zhu, Haibo Wang & Haipeng Xiao. (2023) Effect of inactivated COVID-19 vaccine on the negative conversion of nucleic acid in asymptomatic or mild patients with COVID-19. BMC Infectious Diseases 23:1.
Crossref
Zhuxian Zhu, Jixu Cai, Qiang Tang, Yin-yuan Mo, Tiantian Deng, Xiaoyu Zhang, Ke Xu, Beishou Wu, Haicheng Tang & Ziqiang Zhang. (2023) Circulating eosinophils associated with responsiveness to COVID-19 vaccine and the disease severity in patients with SARS-CoV-2 omicron variant infection. BMC Pulmonary Medicine 23:1.
Crossref
Shiyao Xu, Jincheng Li, Hongyuan Wang, Fuzhen Wang, Zundong Yin & Zhifeng Wang. (2023) Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis. BMC Medicine 21:1.
Crossref
Alessandro Sette, John SidneyShane Crotty. (2023) T Cell Responses to SARS-CoV-2. Annual Review of Immunology 41:1, pages 343-373.
Crossref
Ruoqiong Huang, Liyang Ying, Jiangmei Wang, Jie Xia, Yanjun Zhang, Haiyan Mao, Ruoyang Zhang, Ruoxi Zang, Zhenkai Le, Qiang Shu & Jianguo Xu. (2023) Non-spike and spike-specific memory T cell responses after the third dose of inactivated COVID-19 vaccine. Frontiers in Immunology 14.
Crossref
Hangtian Guo, Yixuan Yang, Tiantian Zhao, Yuchi Lu, Yan Gao, Tinghan Li, Hang Xiao, Xiaoyu Chu, Le Zheng, Wanting Li, Hao Cheng, Haibin Huang, Yang Liu, Yang Lou, Henry C. Nguyen, Chao Wu, Yuxin Chen, Haitao Yang & Xiaoyun Ji. (2023) Mechanism of a rabbit monoclonal antibody broadly neutralizing SARS-CoV-2 variants. Communications Biology 6:1.
Crossref
Xuan Deng, Yuchen Zhao, Shenyu Wang, Hanqing He, Zhiping Chen, Yang Zhou, Rui Yan, Xuewen Tang, Yao Zhu & Xiaoping Xu. (2023) Assessing COVID-19 Vaccine Booster Hesitancy Using the Modified 5C Scale in Zhejiang Province, China: A Cross-Sectional Study. Vaccines 11:3, pages 706.
Crossref
Hangjie Zhang, Qianhui Hua, Nani Nani Xu, Xinpei Zhang, Bo Chen, Xijun Ma, Jie Hu, Zhongbing Chen, Pengfei Yu, Huijun Lei, Shenyu Wang, Linling Ding, Jian Fu, Yuting Liao, Juan Yang, Jianmin Jiang & Huakun Lv. (2023) Evaluation of antibody kinetics and durability in healthy individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): A cross-sectional and cohort study in Zhejiang, China. eLife 12.
Crossref
Ganggang Miao, Zhiqiang Chen, Hengsong Cao, Wenhao Wu, Xi Chu, Hanyuan Liu, Leyao Zhang, Hongfei Zhu, Hongzhou Cai, Xiaolan Lu, Junfeng Shi, Yuan Liu & Tingting Feng. (2023) From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era. Biomedicine & Pharmacotherapy 158, pages 114208.
Crossref
Roberta Marzi, Jessica Bassi, Chiara Silacci-Fregni, Istvan Bartha, Francesco Muoio, Katja Culap, Nicole Sprugasci, Gloria Lombardo, Christian Saliba, Elisabetta Cameroni, Antonino Cassotta, Jun Siong Low, Alexandra C. Walls, Matthew McCallum, M. Alejandra Tortorici, John E. Bowen, Exequiel A. DellotaJr.Jr., Josh R. Dillen, Nadine Czudnochowski, Laura Pertusini, Tatiana Terrot, Valentino Lepori, Maciej Tarkowski, Agostino Riva, Maira Biggiogero, Alessandra Franzetti-Pellanda, Christian Garzoni, Paolo Ferrari, Alessandro Ceschi, Olivier Giannini, Colin Havenar-Daughton, Amalio Telenti, Ann Arvin, Herbert W. Virgin, Federica Sallusto, David Veesler, Antonio Lanzavecchia, Davide Corti & Luca Piccoli. (2023) Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape. iScience 26:1, pages 105726.
Crossref
Saskia Meyer, Isaac Blaas, Ravi Chand Bollineni, Marina Delic-Sarac, Trung T. Tran, Cathrine Knetter, Ke-Zheng Dai, Torfinn Støve Madssen, John T. Vaage, Alice Gustavsen, Weiwen Yang, Lise Sofie Haug Nissen-Meyer, Karolos Douvlataniotis, Maarja Laos, Morten Milek Nielsen, Bernd Thiede, Arne Søraas, Fridtjof Lund-Johansen, Even H. Rustad & Johanna Olweus. (2023) Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants. Cell Reports 42:1, pages 111995.
Crossref
Yue Tao, Mengyin Ma, Fenghua Hu, Ming Li, Yu Geng, Yawen Wan, Minxin Mao, Lin Chen, Ya Shen, Liguo Zhu, Han Shen & Yuxin Chen. (2022) A longitudinal study of humoral immune responses induced by a 3-dose inactivated COVID-19 vaccine in an observational, prospective cohort. BMC Immunology 23:1.
Crossref
J. Fevery & K. Dallmeier. (2022) Immunologische aspecten van Covid-19-ziekte en van vaccinatie tegen SARS-CoV-2 Deel 2: Variaties van het immuunantwoord individueel en in de tijd bij een infectie met SARS-CoV-2 en bij vaccinatie. Tijdschrift voor Geneeskunde.
Crossref
Ali A. Rabaan, Abbas Al Mutair, Khalid Hajissa, Amal H. Alfaraj, Jumana M. Al-Jishi, Mashael Alhajri, Sara Alwarthan, Shahab A. Alsuliman, Amal H. Al-Najjar, Ibrahim A. Al Zaydani, Ghadeer Hassan Al-Absi, Sana A. Alshaikh, Mohammed S. Alkathlan, Souad A. Almuthree, Abdulsalam Alawfi, Amer Alshengeti, Fatimah Z. Almubarak, Mohammed S. Qashgari, Areeg N. K. Abdalla & Saad Alhumaid. (2022) A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants. Vaccines 10:10, pages 1655.
Crossref
Vidya Arankalle, Archana Kulkarni-Munje, Ruta Kulkarni, Sonali Palkar, Rahul Patil, Jitendra Oswal, Sanjay Lalwani & Akhilesh Chandra Mishra. (2022) Immunogenicity of two COVID-19 vaccines used in India: An observational cohort study in health care workers from a tertiary care hospital. Frontiers in Immunology 13.
Crossref
Li-Jun Duan, Wen-Guo Jiang, Zhuang-Ye Wang, Lin Yao, Ka-Li Zhu, Qing-Chuan Meng, Bao-Shan Wang, Li-Bo Li, Guo-Lin Wang & Mai-Juan Ma. (2022) Neutralizing immunity against SARS-CoV-2 Omicron BA.1 by infection and vaccination. iScience 25:9, pages 104886.
Crossref
Sze-Tsing Zee, Lam-Fung Kwok, Ka-Man Kee, Ling-Hiu Fung, Wing-Pan Luk, Tsun-Leung Chan, Chin-Pang Leung, Pik-Wa Yu, Jhan Hung, Kit-Ying SzeTo, Wai-Leng Chan, Siu-Fai Tang, Wai-Chi Lin, Shiu-Kwan Ma, Koon-Hung Lee, Chor-Chiu Lau & Wai-Hung Yung. (2022) Impact of COVID-19 Vaccination on Healthcare Worker Infection Rate and Outcome during SARS-CoV-2 Omicron Variant Outbreak in Hong Kong. Vaccines 10:8, pages 1322.
Crossref
Dorota Zarębska-Michaluk, Chenlin Hu, Michał Brzdęk, Robert Flisiak & Piotr Rzymski. (2022) COVID-19 Vaccine Booster Strategies for Omicron SARS-CoV-2 Variant: Effectiveness and Future Prospects. Vaccines 10:8, pages 1223.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.